It's fall in Toronto: we've entered the time of year where our weather starts to fluctuate wildly and unpredictably. The weather actually timed it perfectly for back to school: on Labour Day it was warm and sunny, and the next morning it was suddenly cool-ish fall temperatures.
So it's time for another update on medtech articles you don't want to miss. Check out the articles below for information on Asia's medtech market, the top 20 medtech companies of 2018, pediatric medical devices, health care costs around the world, confidence in the medtech industry, and of course, more on the medical device excise tax.
  • This quiz put on by MD+DI called How Well Do You Know Asia's Medtech Market is a fun way of testing your knowledge and maybe learning some things about this diverse and fast-growing medtech space. Clinica also wrote an interesting article with some tips on navigating the Asian medtech market.
  • Evaluate Pharma has also recently put out a list of the top 20 medtech companies of 2018. While the names of familiar, there's been some shuffling around since the list we saw at the end of last year.  For example, this list is predicting that companies in the large and fast-growing IVD space, such as Roche, Siemens, Abbott Laboratories, Thermo Fisher Scientific, and Danaher will have particular luck. Meanwhile, companies with big orthopedic portfolios will suffer due to softness in that industry.
  • No list would be complete without mentioning the medical device excise tax. Recently, earnings from the tax passed the $1 billion mark despite vigorous efforts to get it repealed. The idea is that this $1 billion will get funnelled back into health care to help fund the initiatives under Obamacare, although medical device companies view it as a job- and innovation-squashing demon. According to this infographic, the most jobs will be lost in California due to the tax.
  • Are kids slipping through the cracks? More concerns have been brought up lately on whether medical devices adequately meet the needs of kids by and large, these devices are designed for adults.  Some companies have made some strides in this direction; for example, Novo Nordisk recently received FDA clearance for a kid-friendly insulin pen.
  • We know that health care costs in the US are high. I've read about it a lot, but this infographic put it in the most interesting way for me see what you guys think.
  • Our recent Medtech Confidence Index shows that confidence in the US and Europe is recovering, as confidence in the rest of the world slows. This is likely partially due to the slowdown in the BRIC markets, which is described in detail in this Economist article.

DRG becomes Clarivate

View Now